A Small Molecule Screen Identifies an Inhibitor of DNA Repair Inducing the Degradation of TFIIH and the Chemosensitization of Tumor Cells to Platinum
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, treatment with spironolactone, which degrades XPB and prevents TFIIH from being recruited to the TC-NER complex [76], disrupted the INTS11 binding to these TC-NER factors.”
From Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart (2026) · cites this paper as [76]
In the citing paper
“To further test our model, we examined the role of Integrator in Pol II release following acute TFIIH depletion by treating cells with spironolactone, which induces rapid degradation of the TFIIH subunit XPB [76].”
From Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart (2026) · cites this paper as [76]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hickson, I., Zhao, Y., Richardson, C. J., Green, S. J., Martin, N. M. B., Orr, A. I., Reaper, P. M., Jackson, S. P., Curtin, N. J., & Smith, G. C. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2727 · Cited by 1,220
Molecular mechanism of nucleotide excision repair
de Laat, W. L., Jaspers, N. G. J., & Hoeijmakers, J. H. J. (1999) · Genes & Development · doi:10.1101/gad.13.7.768 · Cited by 1,122
Sugasawa, K., Ng, J. M. Y., Masutani, C., Iwai, S., van der Spek, P. J., Eker, A. P. M., Hanaoka, F., Bootsma, D., & Hoeijmakers, J. H. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80132-x · Cited by 899
Nucleotide excision repair and human syndromes
de Boer, J., & Hoeijmakers, J. H. J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.453 · Cited by 674
Molecular Mechanisms of Mammalian Global Genome Nucleotide Excision Repair
Gillet, L. C. J., & Schärer, O. D. (2006) · Chemical Reviews · doi:10.1021/cr040483f · Cited by 642 · cited 1×
“SP Increases Cell Sensitivity to UV and Cisplatin Treatment A hallmark of NER-deficient cells is their sensitivity to UV- or cisplatin-induced DNA lesions (Furuta et al., 2002; Gillet and Schärer, 2006).”
BackgroundFousteri, M., & Mullenders, L. H. (2008) · Cell Research · doi:10.1038/cr.2008.6 · Cited by 487
Ogi, T., Limsirichaikul, S., Overmeer, R. M., Volker, M., Takenaka, K., Cloney, R., Nakazawa, Y., Niimi, A., Miki, Y., Jaspers, N. G., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.009 · Cited by 392
Le May, N., Mota-Fernandes, D., Vélez-Cruz, R., Iltis, I., Biard, D., & Egly, J. M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.03.004 · Cited by 228
Self-citationKeriel, A., Stary, A., Sarasin, A., Rochette-Egly, C., & Egly, J.-M. (2002) · Cell · doi:10.1016/s0092-8674(02)00692-x · Cited by 192 · cited 1×
“Transactivation Assay RAR-dependent gene activation was performed as described (Keriel et al., 2002).”
MethodSelf-citation
Research works printed but not linked: 31
- Barakat, 2009, Characterization of an inhibitory dynamic pharmacophore for the ERCC1-XPA interaction using a combined molecular dynamics and virtual screening approach, J. Mol. Graph. Model., 28, 113, 10.1016/j.jmgm.2009.04.009 · DOI
- Barakat, 2012, DNA repair inhibitors: the next major step to improve cancer therapy, Curr. Top. Med. Chem., 12, 1376, 10.2174/156802612801319070 · DOI
- Burnett, 2012, RNA-based therapeutics: current progress and future prospects, Chem. Biol., 19, 60, 10.1016/j.chembiol.2011.12.008 · DOI · Paper page
- Coin, 1998, Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH, Nat. Genet., 20, 184, 10.1038/2491 · DOI · Paper page
- Coin, 2006, p8/TTD-A as a repair-specific TFIIH subunit, Mol. Cell, 21, 215, 10.1016/j.molcel.2005.10.024 · DOI
- Coleman, 2013, Latest research and treatment of advanced-stage epithelial ovarian cancer, Nat. Rev. Clin. Oncol., 10, 211, 10.1038/nrclinonc.2013.5 · DOI · Paper page
- Compe, 2012, TFIIH: when transcription met DNA repair, Nat. Rev. Mol. Cell Biol., 13, 343, 10.1038/nrm3350 · DOI · Paper page
- de Gasparo, 1987, Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro, J. Pharmacol. Exp. Ther., 240, 650, 10.1016/S0022-3565(25)22580-0 · DOI · Paper page
- Furuta, 2002, Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells, Cancer Res., 62, 4899
- Galanski, 2006, Recent developments in the field of anticancer platinum complexes, Recent Patents Anticancer. Drug Discov., 1, 285, 10.2174/157489206777442287 · DOI · Paper page
- Gerard, 1991, Purification and interaction properties of the human RNA polymerase B(II) general transcription factor BTF2, J. Biol. Chem., 266, 20940, 10.1016/S0021-9258(18)54801-8 · DOI · Paper page
- Jin, 2007, Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging, Nature, 447, 1135, 10.1038/nature05902 · DOI · Paper page
- Kelland, 2007, The resurgence of platinum-based cancer chemotherapy, Nat. Rev. Cancer, 7, 573, 10.1038/nrc2167 · DOI · Paper page
- Köberle, 2010, Cisplatin resistance: preclinical findings and clinical implications, Biochim. Biophys. Acta, 1806, 172
- Le May, 2012, Poly (ADP-ribose) glycohydrolase regulates retinoic acid receptor-mediated gene expression, Mol. Cell, 48, 785, 10.1016/j.molcel.2012.09.021 · DOI
- Lehmann, 2011, DNA polymerases and repair synthesis in NER in human cells, DNA Repair (Amst.), 10, 730, 10.1016/j.dnarep.2011.04.023 · DOI · Paper page
- Los, 1994, Hepatic metabolism of spironolactone. Production of 3-hydroxy-thiomethyl metabolites, Drug Metab. Dispos., 22, 903, 10.1016/S0090-9556(25)08434-X · doi:10.1016/s0090-9556(25)08434-x
- Lumb, 1978, Effects in animals of chronic administration of spironolactone—a review, J. Environ. Pathol. Toxicol., 1, 641
- Mori, 1991, Simultaneous establishment of monoclonal antibodies specific for either cyclobutane pyrimidine dimer or (6-4)photoproduct from the same mouse immunized with ultraviolet-irradiated DNA, Photochem. Photobiol., 54, 225, 10.1111/j.1751-1097.1991.tb02010.x · DOI · Paper page
- O’Donovan, 1994, XPG endonuclease makes the 3′ incision in human DNA nucleotide excision repair, Nature, 371, 432, 10.1038/371432a0 · DOI · Paper page
- Oksenych, 2009, Molecular insights into the recruitment of TFIIH to sites of DNA damage, EMBO J., 28, 2971, 10.1038/emboj.2009.230 · DOI
- Petitprez, 2013, Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status, Int. J. Oncol., 42, 1644, 10.3892/ijo.2013.1868 · DOI
- Poindessous, 2003, Enhanced antitumor activity of irofulven in combination with 5-fluorouracil and cisplatin in human colon and ovarian carcinoma cells, Int. J. Oncol., 23, 1347
- Riedl, 2003, The comings and goings of nucleotide excision repair factors on damaged DNA, EMBO J., 22, 5293, 10.1093/emboj/cdg489 · DOI · Paper page
- Sijbers, 1996, Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease, Cell, 86, 811, 10.1016/S0092-8674(00)80155-5 · DOI · Paper page
- Soares, 2011, Trabectedin and its C subunit modified analogue PM01183 attenuate nucleotide excision repair and show activity toward platinum-resistant cells, Mol. Cancer Ther., 10, 1481, 10.1158/1535-7163.MCT-11-0252 · DOI
- Vermeulen, 2000, Sublimiting concentration of TFIIH transcription/DNA repair factor causes TTD-A trichothiodystrophy disorder, Nat. Genet., 26, 307, 10.1038/81603 · DOI
- Volker, 2001, Sequential assembly of the nucleotide excision repair factors in vivo, Mol. Cell, 8, 213, 10.1016/S1097-2765(01)00281-7 · DOI · Paper page
- Weeda, 1997, The XPB subunit of repair/transcription factor TFIIH directly interacts with SUG1, a subunit of the 26S proteasome and putative transcription factor, Nucleic Acids Res., 25, 2274, 10.1093/nar/25.12.2274 · DOI · Paper page
- Willmore, 2004, A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia, Blood, 103, 4659, 10.1182/blood-2003-07-2527 · DOI · Paper page
- Yang, 2007, Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics, Cancer Res., 67, 9472, 10.1158/0008-5472.CAN-07-0568 · DOI · Paper page
Cited by
The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy
Goldstein, M., & Kastan, M. B. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-081313-121208 · Cited by 590
“Although no specific NER inhibitors are currently available, several drugs initially designed for other purposes, such as cyclosporine A (88), cetuximab (89), and spironolactone (90), were shown to inhibit NER by downregulating expression of NER factors and to increase sensitivity to platinum agents.”
BackgroundOvercoming cancer therapeutic bottleneck by drug repurposing
Zhang, Z., Zhou, L., Xie, N., Nice, E. C., Zhang, T., Cui, Y., & Huang, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00213-8 · Cited by 516
Martella, C., Tollenaere, A. I., Waast, L., Lacombe, B., Groussaud, D., Margottin-Goguet, F., Ramirez, B. C., & Pique, C. (2020) · Journal of Virology · doi:10.1128/jvi.02171-19 · Cited by 12
van der Woude, M., Davó-Martínez, C., Thijssen, K. L., Vermeulen, W., & Lans, H. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad642 · Cited by 11
Blom, C. M. A., Gómez-Vázquez, E., van Sluis, M., & Marteijn, J. A. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag1068
Metadata
- Authors
- Alekseev, S., Ayadi, M., Brino, L., Egly, J.-M., Larsen, A. K., & Coin, F.
- Venue
- Chemistry & Biology
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 21
- Issue
- 3
- Pages
- 398-407
- ISSN
- 1074-5521
- Cited by
- 98
- References
- 9
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 385 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Small Molecule Screen Identifies an Inhibitor of DNA Repair Inducing the Degradation of TFIIH and the Chemosensitization of Tumor Cells to Platinum. https://app.cochat.ai/papers/10.1016/j.chembiol.2013.12.014
- The paper
- Alekseev, S., Ayadi, M., Brino, L., Egly, J.-M., Larsen, A. K., & Coin, F. (2014). A Small Molecule Screen Identifies an Inhibitor of DNA Repair Inducing the Degradation of TFIIH and the Chemosensitization of Tumor Cells to Platinum. Chemistry & Biology. https://doi.org/10.1016/j.chembiol.2013.12.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.